Postdoctoral positions are available in the laboratory of Dr. Christian Hurtz. The Hurtz lab is NIH/NCI funded and conducts basic and translational research with a focus on identifying novel treatment strategies for patients with acute lymphoblastic leukemia (ALL).
The available postdoctoral research projects focus on:
1) Elucidate oncogene independent signaling activation and determine alternative treatment strategies for patients with high-risk Philadelphia chromosome-like ALL.
2) Validate if inhibition of STAT5 signaling results in V(D)J mediated DNA-damage and determine the importance of DNA repair mechanisms to induce drug resistance.
3) Determine if forced pharmacologic hyperactivation of B cell receptor signaling pathways results in negative selection of malignant cells and validate if signaling hyperactivation is a feasible therapy option for KMT2A-R ALL patients.
Highly motivated applicants with a PhD degree in cancer biology, immunology, molecular biology, or a related area are encouraged to apply. Practical experience with molecular and cellular biology techniques and animal models is required as well as at least 1 first author publication. Preference will be given to recently graduated candidates with a strong career motivation who resides in the US. Competitive stipend and a generous benefits package commensurate with experience will be provided.
To learn more about our research please visit:
Please submit your application electronically with curriculum vitae, a cover letter with a brief description of research experience, and the names/phone number/emails of three references to:
Dr. Christian Hurtz
Fels Cancer Institute for Personalized Medicine
Lewis Katz School of Medicine at Temple University
Philadelphia, PA 19140